TABLE 2.
miRNA | miRNA expression levels for TB cases vs LTBI controls |
|||||
---|---|---|---|---|---|---|
Agilent microarray results (case group, n = 20; control group, n = 20) |
RT-qPCR results (case group, n = 73; control group, n = 77) |
|||||
Fold-change | P b | Regulation | Fold-change | P b | Regulation | |
hsa-miR-16-5p | 0.27 | <0.001 | Down | 0.45 | <0.001 | Down |
hsa-miR-197-5p | 2.59 | <0.001 | Up | 0.99 | 0.482 | NA |
hsa-miR-451a | 0.42 | 0.009 | Down | 0.22 | <0.001 | Down |
hsa-miR-671-5p | 2.81 | <0.001 | Up | 0.63 | 0.005 | Down |
hsa-miR-6760-3p | 2.77 | <0.001 | Up | 2.08 | 0.043 | Up |
RT-qPCR, real-time quantitative PCR; LTBI, latent tuberculosis infection; miRNA, microRNA; TB, tuberculosis; NA, not applicable.
For Wilcoxon rank-sum test, P < 0.01 was considered statistically significant.